Գլխավոր Թոփ լուրեր Լրահոս Վիդեո Թրենդ

IDBank Announces the Launch of the IDDistributor Financial ToolSafe Workplace as a Guarantee of DevelopmentSpring Promotion at Megamall from Idram&IDBank“We want to buy your item, please provide your card details.” IDBank warns about fraud on classified platforms Ucom Fellowship 2025 Concludes as Top Eco-Startups Secure FundingIDBank Goes International: Mher Abrahamyan's Interview with the Los Angeles TimesAraratBank Earns RIA Money Transfer’s Partner of the Year in Armenia for the Seventh Consecutive YearUcom Supports the “DemArDem 2026” Regional Youth Forum ZCMC еstablishes Sustainability, ESG and Risk Committee Parallels Between the “Real Armenia Ideology” and Soviet and Turkish Approaches to the DiasporaNew Offer - Up to AMD 5 Million - Consolidate your Loans and Switch to AraratBankNew Promotion at Yerevan Mall Ahead of March 8: Idram&IDBankUBPay and MoneyTO Launch Money Transfers from Armenia to the UK In Celebration of the Spring Holidays Ucom Offers Unity Packages on Special Terms Ameriabank Becomes the First Armenian Company in the List of the 100 Largest Companies on the London Stock Exchange as a Member of Lion Finance GroupIDBank Expands Travel Benefits of Premium CardsFree Calls and SMS Messages from Ucom for Subscribers in the Middle EastLove Is… Card by Unibank – An Iconic Design and a Romantic Trip for Two to Paris Customer Appreciation Day at IDBank’s Echmiadzin BranchUcom Fellowship Incubation Program Participants Visit Ucom Individuals and businesses, near and far, all welcomeTrust and reach across the globeChoosing the Best Gifts for March 8 and Paying with the Idram&IDBank AppUcom Spring Offer: HONOR X7d 5G Smartphone and Valuable GiftsAraratBank: Update+ - New Loan Offer with 2% Cashback “My phone rang…”: IDBank warns about a rise in fraud using the “call from the bank” scheme.Ucom Is Recognized as Armenia’s No. 1 Operator for the Fastest Mobile Internet and the Best Fixed Network Unibank’s perpetual bonds have been listed on the Armenia Securities Exchange Armenian Company E-auto to Officially Represent HONGQI Vehicles in Georgia2% Cashback on Payments Made with AraratBank Arca CardsOrder an IDBank Arca Classic card and enjoy up to 2% cashbackIDBank has summed up the raffle held within the framework of IDsalary payroll package: 55 lucky winners have received their prizes Ucom and Hero House Yerevan Continue Cooperation KardaLove 5th Anniversary Festival Held under the Title Sponsorship of AraratBankAmeriabank Opens a New Branch in Artashat: Special Offers for New CustomersDangerous Generosity: IDBank Warns of a Rise in Fake Online SurveysJustice Turned Into a Show: The Real Purpose Behind the Case Against Vahe HakobyanIdram, Mediamax and Hayordi Foundation Launch Initiative Ahead of Book Giving DayAraratBank Receives Mastercard “Excellence in Strategic Marketing” AwardIDBank has opened a representative office in Glendale, CaliforniaTeam Holding Announces the Launch of the Second Tranche of Its USD Bond Placement. Underwriter - Freedom Broker ArmeniaUcom Services Can Now Be Paid Via Fast Shift Team and the French University in Armenia Help 120 Students Gain Real-World ExperienceUcom Offers Comprehensive Internal Network (LAN) Building Services for Corporate Clients Unibank Became an A-Level Member of the Armenia British Business Chamber Winter adventures continue at Myler: Idram&IDBankWith the Support of AraratBank, KardaLove 5th Anniversary Festival Returns in a New FormatThe Power of One Dram — to Mathemik NGOIDBank’s Nor Nork branch has reopenedOn the impossibility of making payments via Idram for telecommunication operators’ services and the current situation
Lifestyle

1 in 4 people face side effects after getting COVID-19 vaccine

One in four people experiences side effects after being vaccinated against coronavirus. These are mostly minor side effects like pain at the injection site or headache, Lancet Infectious Diseases reported.

Analysis of data from the ZOE COVID Symptom Study, conducted by researchers at King's College London, found that side effects in the general population after vaccination with Pfizer and AstraZeneca were much lower than those reported in the trials.

The study also reported a significant reduction in infection rates from 12 to 21 days after the first dose of Pfizer (58% reduction) and AstraZeneca (39% reduction) compared to controls. The reduction in infection at least 21 days after the first dose is 69% for Pfizer and 60% for AstraZeneca.

Research has shown that:

  • 25.4% of vaccinated people reported one or more systemic side effects, while 66.2% reported one or more local side effects.
  • 13.5% of participants reported side effects after the first dose of Pfizer, 22.0% after the second dose of Pfizer, and 33.7% after the first dose of AstraZeneca.
  • The most common systemic side effect was a headache. 7.8% of people reported headaches after the first dose of Pfizer and 13.2% after the second dose of Pfizer. 22.8% of people who received the first dose of the AstraZeneca vaccine reported headaches.
  • The second most common systemic side effect was fatigue. 8.4% and 14.4% of participants reported fatigue after the first and second doses of the Pfizer vaccine, and 21.1% reported fatigue after the first dose of the AstraZeneca vaccine.
  • The most common localized side effect was soreness: 57.2% and 50.9% after the first and second doses of Pfizer vaccine and 49.3% after the first dose of AstraZeneca vaccine.

Side effects were more common in people under the age of 55 and in women.